{"id":344152,"date":"2020-07-31T19:06:35","date_gmt":"2020-08-01T02:06:35","guid":{"rendered":"https:\/\/nai500.com\/blog\/2020\/07\/pfizer-biontech-pledge-120m-doses-of-covid-vaccine-to-japan-revive-therapeutics-on-go-with-late-stage-study-of-bucillamine-in-covid-19\/"},"modified":"2020-07-31T19:07:09","modified_gmt":"2020-08-01T02:07:09","slug":"%e8%be%89%e7%91%9e%e5%85%ac%e5%8f%b8%e5%92%8c-biontech-%e6%89%bf%e8%af%ba%e5%90%91%e6%97%a5%e6%9c%ac%e6%8f%90%e4%be%9b-covid-19-%e7%96%ab%e8%8b%97-revive-therapeutics-%e5%b1%95%e5%bc%80%e5%b8%83","status":"publish","type":"post","link":"https:\/\/nai500.com\/zh-hans\/blog\/2020\/07\/%e8%be%89%e7%91%9e%e5%85%ac%e5%8f%b8%e5%92%8c-biontech-%e6%89%bf%e8%af%ba%e5%90%91%e6%97%a5%e6%9c%ac%e6%8f%90%e4%be%9b-covid-19-%e7%96%ab%e8%8b%97-revive-therapeutics-%e5%b1%95%e5%bc%80%e5%b8%83\/","title":{"rendered":"\u533b\u7597\u4fdd\u5065\u7cbe\u9009\u2014\u2014\u8f89\u745e\u516c\u53f8\u548cBioNTech\u627f\u8bfa\u5411\u65e5\u672c\u63d0\u4f9b1.2\u4ebf\u5242COVID-19\u75ab\u82d7\uff0cRevive Therapeutics\u5c55\u5f00\u5e03\u897f\u62c9\u660e\u6cbb\u7597COVID-19\u7684\u540e\u671f\u7814\u7a76"},"content":{"rendered":"

\u8f89\u745e\u516c\u53f8\u548c<\/strong>BioNTech<\/strong>\u627f\u8bfa\u5411\u65e5\u672c\u63d0\u4f9b<\/strong>1.2<\/strong>\u4ebf\u5242COVID-19<\/strong>\u75ab\u82d7<\/strong><\/h2>\n

\u8f89\u745e(NYSE:PFE)<\/a>\u548cBioNTech (NASDAQ:BNTX)<\/a>\u8868\u793a\uff0c\u5c06\u57282021\u5e74\u4e0a\u534a\u5e74\u4e3a\u65e5\u672c\u63d0\u4f9b1.2\u4ebf\u5242\u57fa\u4e8emRNA\u7684\u65b0\u51a0\u75ab\u82d7\u3002\u8d22\u52a1\u7ec6\u8282\u672a\u62ab\u9732\u3002<\/p>\n

\u4e24\u5bb6\u516c\u53f8\u8868\u793a\uff0c\u4ed6\u4eec\u6709\u671b\u5728\u4eca\u5e7410\u6708\u5f00\u59cb\u5c31\u75ab\u82d7\u8fdb\u884c\u76d1\u7ba1\u5ba1\u67e5\uff0c\u76ee\u6807\u662f\u52302020\u5e74\u5e95\u751f\u4ea7\u591a\u8fbe1\u4ebf\u5242\u65b0\u51a0\u75ab\u82d7\u3002<\/p>\n

\u672c\u5468\u65e9\u4e9b\u65f6\u5019\uff0c\u8f89\u745e\u548cBioNTech\u5ba3\u5e03BNT162b2\u5019\u9009\u75ab\u82d7\u8fdb\u5165\u540e\u671f\u4eba\u4f53\u8bd5\u9a8c\u3002<\/p>\n

Revive Therapeutics<\/strong>\u5c55\u5f00\u5e03\u897f\u62c9\u660e\u6cbb\u7597<\/strong>COVID-19<\/strong>\u7684\u540e\u671f\u7814\u7a76<\/strong><\/h2>\n

FDA\u5df2\u7ecf\u6279\u51c6\u4e86Revive Therapeutics\uff08OTCPK\uff1aRVVTF<\/a>\uff09\u4e00\u98793\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8bc4\u4f30\u5e03\u897f\u62c9\u660e\u5bf9\u8f7b\u5ea6\u81f3\u4e2d\u5ea6COVID-19\u60a3\u8005\u7684\u7597\u6548\u3002<\/p>\n

\u8be5\u7814\u7a76\u5c06\u62db\u52df\u591a\u8fbe1,000\u540d\u53d7\u8bd5\u8005\uff0c\u8fd9\u4e9b\u53d7\u8bd5\u8005\u5c06\u6309\u6807\u51c6\u7684\u62a4\u7406\u6807\u51c6\u63a5\u53d7\u6cbb\u7597\u3002\u4e3b\u8981\u7ec8\u70b9\u6307\u6807\u662f\u572828\u5929\u4e2d\u8fbe\u5230\u4f4f\u9662\u6216\u6b7b\u4ea1\u7efc\u5408\u7ec8\u70b9\u6307\u6807\u7684\u60a3\u8005\u6bd4\u4f8b\u3002<\/p>\n

\u5e03\u897f\u62c9\u660e\u662f\u4e00\u79cd\u6c28\u57fa\u9178\u534a\u80f1\u6c28\u9178\u7684\u884d\u751f\u7269\uff0c\u5728\u65e5\u672c\u548c\u97e9\u56fd\u5df2\u670930\u591a\u5e74\u7684\u6cbb\u7597\u7c7b\u98ce\u6e7f\u5173\u8282\u708e\u7684\u5386\u53f2\u3002<\/p>\n

RedHill<\/strong>\u8fdb\u884c<\/strong>RHB-204<\/strong>\u6cbb\u7597\u80ba\u90e8\u611f\u67d3\u7684\u540e\u671f\u7814\u7a76<\/strong><\/h2>\n

\u7f8e\u56fd\u98df\u54c1\u836f\u54c1\u76d1\u7763\u7ba1\u7406\u5c40\uff08FDA\uff09\u5df2\u6279\u51c6\u8bc4\u4f30RedHill BioPharma\uff08NASDAQ\uff1aRDHL\uff09<\/a>RHB-204\u5728\u7531\u9e1f\u5206\u679d\u6746\u83cc\u590d\u5408\u4f53\uff08MAC\uff09\u611f\u67d3\u5f15\u8d77\u7684\u80ba\u975e\u7ed3\u6838\u5206\u679d\u6746\u83cc\uff08NTM\uff09\u6210\u5e74\u60a3\u8005\u4e2d\u8fdb\u884c\u76843\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/p>\n

\u8be5\u516c\u53f8\u80a1\u4ef7\u4e0a\u6da86%\u3002<\/p>\n

\u9ed8\u514b\u7b2c\u4e8c\u8d22\u5b63\u589e\u957f<\/strong>3%<\/strong><\/h2>\n

\u9ed8\u514b\uff08MRK\uff09<\/a>\u7b2c\u4e8c\u8d22\u5b63\u7ed3\u679c\uff1a<\/p>\n

\u6536\u5165\uff1a108.72\u4ebf\u7f8e\u5143\uff08-7.6%\uff09\u3002<\/p>\n

\u51c0\u6536\u5165\uff1a$30.02\u4ebf\uff08+ 12.4%\uff09;\u6bcf\u80a1\u6536\u76ca\uff1a1.18\u7f8e\u5143\uff08+ 14.6%\uff09;\u975eGAAP\u51c0\u5229\u6da6\uff1a34.84\u4ebf\u7f8e\u5143\uff08+ 3.8%\uff09;\u975eGAAP\u6bcf\u80a1\u6536\u76ca\uff1a1.37\u7f8e\u5143\uff08\u589e\u957f5.4%\uff09\u3002<\/p>\n

\u8be5\u80a1\u76d8\u524d\u4e0a\u6da83%\u3002<\/p>\n

\u518d\u751f\u5143\u4e0e<\/strong>BioNTech<\/strong>\u5408\u4f5c\uff0c\u6cbb\u7597\u9ed1\u8272\u7d20\u7624<\/strong><\/h2>\n

\u518d\u751f\u5143\uff08NASDAQ\uff1aREGN\uff09<\/a>\u5c06\u4e0eBioNTech\uff08NASDAQ\uff1aBNTX\uff09<\/a>\u5408\u4f5c\u8fdb\u884c\u4e00\u9879\u4e34\u5e8a\u8bd5\u9a8c\uff0c\u8be5\u8bd5\u9a8c\u8bc4\u4f30PD-1\u6291\u5236\u5242Libtayo\uff08cemiplimab\uff09\u4e0eBNT111 FixVac\u5019\u9009\u836f\u7269\u8054\u5408\u6cbb\u7597\u665a\u671f\u76ae\u80a4\u75c5\u60a3\u8005\u7684\u9ed1\u8272\u7d20\u7624\u3002<\/p>\n

\u53cc\u65b9\u5c06\u5e73\u5747\u5206\u62c5\u8be5\u8bd5\u9a8c\u7684\u5f00\u53d1\u6210\u672c\uff0c\u8fd8\u5c06\u4fdd\u7559\u5404\u81ea\u4ea7\u54c1\u7684\u5168\u90e8\u5546\u4e1a\u6743\u5229\u3002<\/p>\n

BNT111\u7531\u56db\u79cd\u9ed1\u8272\u7d20\u7624\u6297\u539f\uff08NY-ESO-1\uff0cMAGE-A3\uff0c\u916a\u6c28\u9178\u9176\u548cTPTE\uff09\u7ec4\u6210\u3002\u8be5\u7814\u7a76\u5c06\u5728\u7b2c\u56db\u5b63\u5ea6\u542f\u52a8\u3002<\/p>\n

REGN\u80a1\u4ef7\u4e0a\u6da83%\uff0cBNTX\u80a1\u4ef7\u4e0a\u6da85%\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u8f89\u745e\u516c\u53f8\u548cBioNTech\u627f\u8bfa\u5411\u65e5\u672c\u63d0\u4f9b1.2\u4ebf\u5242COVID-19\u75ab\u82d7 \u8f89\u745e(NYSE:PFE)\u548cBioNTe […]<\/p>\n","protected":false},"author":9,"featured_media":344149,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[427],"tags":[820,455,747,925,459],"class_list":["post-344152","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market-news-zh-hans","tag-820","tag-455","tag-747","tag-925","tag-459","sectors-life-science-zh-hans","locations-china-zh-hans","locations-us-zh-hans","exchange-nasdaq-zh-hans","exchange-nyse-zh-hans"],"acf":[],"_links":{"self":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/344152","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/comments?post=344152"}],"version-history":[{"count":0,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/posts\/344152\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media\/344149"}],"wp:attachment":[{"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/media?parent=344152"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/categories?post=344152"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nai500.com\/zh-hans\/wp-json\/wp\/v2\/tags?post=344152"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}